February 5, 2025
admin
What was the last grey market premium of Amwill Healthcare IPO?
For latest GMP, Click
Subscription status of Amwill Healthcare IPO
|
Amwill Healthcare IPO Price Rs. 111 Lot 1200 shares, Rs. ? Crore |
||||
| QIB | NII x | RII x | Total x | Applications |
| Amount wise bids recd. Rs. ? Crore | ||||
| Note: | ||||
What is the business of Amwill Healthcare?
Founded in August 2017, Amwill Health Care Limited is a derma-cosmetic development company that partners with contract manufacturers, distributors, and third-party product development agencies. These collaborations have strengthened the company’s capabilities in manufacturing, packaging, and distribution.
The company’s product portfolio is categorized into two key areas:
- Development of generic dermatological solutions
- Formulation of targeted treatments for specific dermatological issues
Amwill Health Care primarily operates in the regions of Karnataka, Andhra Pradesh, and Telangana, focusing on building a strong presence in these markets before expanding further to establish a wider customer base.
The company specializes in developing products for a range of dermatological conditions, including acne, fungal infections, anti-aging, histaminic reactions, periorbital hyperpigmentation, scabies, excessive perspiration, trichology concerns, and vitiligo.
As of April 30, 2024, Amwill Health Care employs a total of 59 staff members, with 31 of those dedicated to the marketing team.
Get more information about the company @ https://www.amwillhealthcare.com/
|
Amwill Healthcare IPO Details |
|
| IPO opens on | 5 February 2025 |
| IPO closes on | 7 February 2025 |
| Issue Type | Book Built Issue IPO |
| Issue Size | 5403600 Shares / Rs 59.98 Crore |
| * Fresh Issue | 4403600 Shares / Rs 48.88 Crore |
| * Offer for Sale – | 1000000 shares / Rs. 11.10 crore |
| Market Maker Portion | 271200 Shares |
| Net offer to Public | 5132400 Shares/ Rs 56.97 Crore |
| Face Value per share | Rs. 10 |
| Price Band | Rs. 105-111 |
| Employee discount | Rs. 0 per share |
| Retail Lot Size | 1200 Shares |
| Listing will at | BSE SME |
Shares offered in IPO |
||
| Shares | Rs. (Crore) | |
| QIB (20%) | 1026480 | 11.39 |
| HNI (40%) | 2052960 | 22.79 |
| RII (40%) | 2052960 | 22.79 |
| Total Shares | 5132400 | 56.97 |
| Retail portion will be oversubscribed by |
1711 | |
| Forms | ||
| How much Shares to Apply in this IPO? | ||
| Min Retail Application | 1200 Shares | Rs.133200 |
| Min HNI Application | 2400 Shares | Rs. 266400 |
Who are the Promoters of Amwill Healthcare?
The Promoters of the Company are namely Anand Gandhi and Tarun Gandhi.
What are the Objects of Amwill Healthcare IPO?
The company proposes to utilize the Net Proceeds in the following manner.
- Funding of working capital requirements of the Company
- Marketing and brand-building activities
- General corporate purposes
Tentative timetable |
|
| IPO opens on | 5 February 2025 |
| IPO Closes on | 7 February 2025 |
| IPO Allotment on | 10 February 2025 |
| Refund Initiation | 11 February 2025 |
| Credit of Shares | 11 February 2025 |
| Listing on | 12 February 2025 |
| Registered Office of the Company Amwill Healthcare Limited No. 157, 1st Floor, 2nd Main, r, 2nd Main, 3rd Cross Chamrajpet Bangalore – 560018 |
| Who is the Lead Manager of this IPO? Unistone Capital Pvt Ltd |
|
Who is the Registrar to IPO? |
Amwill Healthcare IPO GMP grey market premium, review, Subscription, allotment, listing estimate
|
Amwill Healthcare IPO Financial & Analytical Ratios |
||||
| Year | Total Income |
Net Profit |
EPS | RoNW |
| Rs.in Crore | Rs.in Crore | Rs. | % | |
| 2021-22 | 27.62 | 2.57 | ||
| 2022-23 | 30.28 | 3.11 | ||
| 2023-24 9M | 36.05 | 11.00 | 7.05 | 70.42 |
| Book Value of the Share on 31.12.2023 |
10.02 | |||
| BV of the Share at cap price after IPO |
Rs. | |||
| Offer Price/upper band | Rs. | 111 | ||
Key Performance
|
|
| Price/EPS of 23-24 | 55.60 |
| Price/BV Ratio | – |
| Debt/Equity Ratio | |
How Amwill Healthcare IPO compares with the Peers?
| As per DRHP | FV | Total | PE |
| Income in | Ratio | ||
| Rs. crore | |||
| Amwill Healthcare | 10 | 30.17 | 55.60 |
| Vaishali Pharma | 10 | 69.66 | 28.47 |
| Trident Pharma | 10 | 31.69 | 26.81 |
# This is only coverage of News related to Grey Market Premium & subject to rates. We do not deal in grey market premium. We do not recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.
Amwill Healthcare IPO Review by Paresh Gordhandas, CA & Research Analyst.
Will post our review soon
+ from fundamental angle: so-so
+ from grey market angle:
Quicklinks
Amwill Healthcare IPO GMP today allotment, review?
Amwill Healthcare IPO GMP grey market premium
Amwill Healthcare IPO GMP
